Royalty Pharma Plc (RPRX)
45.36
-0.17
(-0.37%)
USD |
NASDAQ |
Mar 20, 16:00
45.34
-0.02
(-0.04%)
After-Hours: 20:00
Royalty Pharma Research and Development Expense (Quarterly) : 51.00M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Zymeworks, Inc. | 31.24M |
| PTC Therapeutics, Inc. | 133.13M |
| Johnson & Johnson | 4.268B |
| Cytokinetics, Inc. | 101.54M |
| Veru, Inc. | 1.344M |